PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers:
Current Status of Clinical Trials. Robust clinical evidence that PDE-5Is (such as Sildenafil), alone or in conjunction with traditional vasoactive therapy, improve Raynaud's and Digital Ulcers in systemic sclerosis is still lacking. International Journal of Rheumatology. 2011:392542. (Also see: Digital Ulcer Treatments)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers:
Started by
Joelf
, Apr 21 2012 01:17 PM
No replies to this topic
#1
Joelf
-
- ISN Administrators
-
- 2,695 posts
Platinum Plus Member
- Location:West Sussex
Posted 21 April 2012 - 01:17 PM
Jo Frowde
ISN Sclero Forums Manager
ISN News Guide for Scleroderma Medical News
ISN Chat Host
International Scleroderma Network (ISN)
ISN Sclero Forums Manager
ISN News Guide for Scleroderma Medical News
ISN Chat Host
International Scleroderma Network (ISN)
